Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

Twelve Bio

Main focus: Treatment and diagnostics of genetic diseases

Company stage: Pre-clinical

Diseases: Undisclosed

Genome editing tool: CRISPR-Cas12a

Funding stage: Private

Location: Copenhagen, Denmark


Twelve Bio is a pre-clinical stage gene-editing company that primarily focuses on the Cas12a enzyme. The company is located in Copenhagen, Denmark, as part of the Bioinnovation Institute accelerator, and has yet to disclose its first therapeutic programme.


HashtagTwelve Bio

Company: Twelve Bio
Jobs, banner ads, webinars, sponsored content...
Search CRISPR Medicine